A bioscience professional with two decades of experience and achievements spanning BD, strategic planning, sales, and marketing, I am now leading Business Development for antibody-based first-in-class therapeutics at APITBIO. In this role, my primary focus is on delivering more innovative treatment options to cancer patients worldwide.